Racial differences in risk of spontaneous abortions associated with periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure

Annals of Epidemiology

Volumn 24, Issue 2, 2014, Pages 111-115.e1

  Velez Edwards, Digna R ^a,b   Hartmann, Katherine E ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Disparity; Miscarriage; Nonsteroidal anti inflammatory drugs; Pregnancy; Toxicology

Indexed keywords

NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; SPONTANEOUS ABORTION;

DISPARITY; MISCARRIAGE; NONSTEROIDAL ANTI-INFLAMMATORY DRUGS; PREGNANCY; TOXICOLOGY;

ABORTION, SPONTANEOUS; ADULT; AFRICAN AMERICANS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GESTATIONAL AGE; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; INTERVIEWS AS TOPIC; NONPRESCRIPTION DRUGS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84892961905     PISSN: 10472797     EISSN: 18732585     Source Type: Journal    
DOI: 10.1016/j.annepidem.2013.11.001     Document Type: Article

References (44)

1. Kaufman D.W., Kelly J.P., Rosenberg L., Anderson T.E., Mitchell A.A. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002, 287(3):337-344.
2. Paulose-Ram R., Hirsch R., Dillon C., Losonczy K., Cooper M., Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepidemiol Drug Saf 2003, 12(4):315-326.
3. Curhan G.C., Bullock A.J., Hankinson S.E., Willett W.C., Speizer F.E., Stampfer M.J. Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf 2002, 11(8):687-693.
4. Olesen C., Steffensen F.H., Nielsen G.L., de Jong-van den Berg, Olsen J., Sorensen H.T. Drug use in first pregnancy and lactation: a population-based survey among Danish women. The EUROMAP group. Eur J Clin Pharmacol 1999, 55(2):139-144.
5. Li D.K., Liu L., Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003, 327(7411):368.
6. Nielsen G.L., Sorensen H.T., Larsen H., Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ 2001, 322(7281):266-270.
7. Nakhai-Pour H.R., Broy P., Sheehy O., Berard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ 2011.
8. Agrawal A., Fentiman I.S. NSAIDs and breast cancer: a possible prevention and treatment strategy. Int J Clin Pract 2008, 62(3):444-449.
9. Lin H.J., Lakkides K.M., Keku T.O., Reddy S.T., Louie A.D., Kau I.H., et al. Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 2002, 11(11):1305-1315.
10. Burroughs V.J., Maxey R.W., Levy R.A. Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment. J Natl Med Assoc 2002, 94(10 Suppl):1-26.
11. Davies N.M., McLachlan A.J., Day R.O., Williams K.M. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet 2000, 38(3):225-242.
12. Mukherjee S, Velez Edwards D, Hartmann K. Health disparities and the risk of miscarriage. In press. 2012.
13. Menon R., Velez D.R., Thorsen P., Vogel I., Jacobsson B., Williams S.M., et al. Ethnic differences in key candidate genes for spontaneous preterm birth: TNF-alpha and its receptors. Hum Hered 2006, 62(2):107-118.
14. Menon R., Pearce B., Velez D.R., Merialdi M., Williams S.M., Fortunato S.J., et al. Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants. Reprod Biol Endocrinol 2009, 7:62.
15. Velez D.R., Menon R., Thorsen P., Jiang L., Simhan H., Morgan N., et al. Ethnic differences in interleukin 6 (IL-6) and IL6 receptor genes in spontaneous preterm birth and effects on amniotic fluid protein levels. Ann Hum Genet 2007, 71(Pt 5):586-600.
16. Velez D.R., Fortunato S.J., Thorsen P., Lombardi S.J., Williams S.M., Menon R. Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants. PLoS One 2008, 3(9):e3283.
17. Velez D.R., Fortunato S.J., Morgan N., Edwards T.L., Lombardi S.J., Williams S.M., et al. Patterns of cytokine profiles differ with pregnancy outcome and ethnicity. Hum Reprod 2008, 23(8):1902-1909.
18. Velez D.R., Fortunato S.J., Williams S.M., Menon R. Interleukin-6 (IL-6) and receptor (IL6-R) gene haplotypes associate with amniotic fluid protein concentrations in preterm birth. Hum Mol Genet 2008, 17(11):1619-1630.
19. Velez D.R., Fortunato S., Thorsen P., Lombardi S.J., Williams S.M., Menon R. Spontaneous preterm birth in African Americans is associated with infection and inflammatory response gene variants. Am J Obstet Gynecol 2009, 200(2):209-227.
20. Bergh P.A., Navot D. The impact of embryonic development and endometrial maturity on the timing of implantation. Fertil Steril 1992, 58(3):537-542.
21. Duffy D.M., Stouffer R.L. The ovulatory gonadotrophin surge stimulates cyclooxygenase expression and prostaglandin production by the monkey follicle. Mol Hum Reprod 2001, 7(8):731-739.
22. Fazleabas A.T., Kim J.J., Srinivasan S., Donnelly K.M., Brudney A., Jaffe R.C. Implantation in the baboon: endometrial responses. Semin Reprod Endocrinol 1999, 17(3):257-265.
23. Frank G.R., Brar A.K., Cedars M.I., Handwerger S. Prostaglandin E2 enhances human endometrial stromal cell differentiation. Endocrinology 1994, 134(1):258-263.
24. Kelly R.W., Carr G.G., Elliott C.L., Tulppala M., Critchley H.O. Prostaglandin and cytokine release by trophoblastic villi. Hum Reprod 1995, 10(12):3289-3292.
25. Kim J.J., Wang J., Bambra C., Das S.K., Dey S.K., Fazleabas A.T. Expression of cyclooxygenase-1 and -2 in the baboon endometrium during the menstrual cycle and pregnancy. Endocrinology 1999, 140(6):2672-2678.
26. Kistner E.O., Weinberg C.R. Method for using complete and incomplete trios to identify genes related to a quantitative trait. Genet Epidemiol 2004, 27(1):33-42.
27. Norwitz E.R., Schust D.J., Fisher S.J. Implantation and the survival of early pregnancy. N Engl J Med 2001, 345(19):1400-1408.
28. Pall M., Friden B.E., Brannstrom M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study. Hum Reprod 2001, 16(7):1323-1328.
29. Sookvanichsilp N., Pulbutr P. Anti-implantation effects of indomethacin and celecoxib in rats. Contraception 2002, 65(5):373-378.
30. Wilcox A.J., Baird D.D., Weinberg C.R. Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 1999, 340(23):1796-1799.
31. Lala P.K., Scodras J.M., Graham C.H., Lysiak J.J., Parhar R.S. Activation of maternal killer cells in the pregnant uterus with chronic indomethacin therapy, IL-2 therapy, or a combination therapy is associated with embryonic demise. Cell Immunol 1990, 127(2):368-381.
32. Edwards D.R., Aldridge T., Baird D.D., Funk M.J., Savitz D.A., Hartmann K.E. Periconceptional over-the-counter nonsteroidal anti-inflammatory drug exposure and risk for spontaneous abortion. Obstet Gynecol 2012, 120(1):113-122.
33. FDA 11 A.D. October 21 Available from. http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm.
34. Micromedex 2.0. Micromedex 2 0 11 A.D.November 8 Available from. http://www.micromedexsolutions.com/micromedex2/librarian.
35. LexiComp ONLINE. LexiComp ONLINE 11 A.D. November 8 Available from. http://online.lexi.com/crlsql/servlet/crlonline.
36. Epocrates Online Premium. Epocrates Online Premium 11 A.D. November 8 Available from. http://online.epocrates.com/noFrame.
37. DailyMed. Daily Med 11 A.D.November 8 Available from. http://dailymed.nlm.nih.gov/.
38. drugstore.com. Drugstore com 11 A.D. November 8 Available from. http://www.drugstore.com/.
39. Dupont W. Statistical Modeling for Biomedical Researchers: A Simple Introduction to the Analysis of Complex Data. 2nd ed. Cambridge University Press; 2009.
40. Howards P.P., Hertz-Picciotto I., Weinberg C.R., Poole C. Misclassification of gestational age in the study of spontaneous abortion. Am J Epidemiol 2006, 164(11):1126-1136.
41. Macarthur M., Sharp L., Hold G.L., Little J., El-Omar E.M. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol Biomarkers Prev 2005, 14(7):1613-1618.
42. Sansbury L.B., Bergen A.W., Wanke K.L., Yu B., Caporaso N.E., Chatterjee N., et al. Inflammatory cytokine gene polymorphisms, nonsteroidal anti-inflammatory drug use, and risk of adenoma polyp recurrence in the polyp prevention trial. Cancer Epidemiol Biomarkers Prev 2006, 15(3):494-501.
43. Haapsamo M., Martikainen H., Rasanen J. Low-dose aspirin and uterine haemodynamics on the day of embryo transfer in women undergoing IVF/ICSI: a randomized, placebo-controlled, double-blind study. Hum Reprod 2009, 24(4):861-866.
44. Steer C.V., Campbell S., Tan S.L., Crayford T., Mills C., Mason B.A., et al. The use of transvaginal color flow imaging after in vitro fertilization to identify optimum uterine conditions before embryo transfer. Fertil Steril 1992, 57(2):372-376.